Postmarketing reporting of adverse drug experiences

Author: Current through August 31, 2023

Pages: 21 C.F.R. §314.80

Linked as:


Document options

Extract

Postmarketing reporting of adverse drug experiences

No longer available (Autolink)

See the full content of this document

Core Citations

REFERENCE STUB